natgillin/translations-raw huggingface dataset:
Therefore, GANFORT single-dose should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular oedema (e.g. intraocular surgery, retinal vein occlusions, ocular inflammatory disease and diabetic retinopathy).
Zato je potrebna previdnost pri uporabi zdravila GANFORT (enoodmerna oblika) pri bolnikih z afakijo, bolnikih s psevdofakijo oziroma s poškodovano zadnjo lečno kapsulo in pri bolnikih z znanimi dejavniki tveganja za makularni edem (npr. intraokularna operacija, okluzija retinalne vene, vnetna očesna bolezen in diabetična retinopatija).
The safety and efficacy of GANFORT single-dose in children aged less than 18 years has not been established.
Varnosti in učinkovitosti zdravila GANFORT (enoodmerna oblika) pri otrocih, mlajših od 18 let, nista bili dokazani.
The adverse reactions reported in the clinical study using GANFORT single-dose were limited to those earlier reported for either GANFORT (multi-dose formulation) or for the single active substances bimatoprost or timolol.
Neželeni učinki v klinični študiji zdravila GANFORT (enoodmerna oblika) so bili omejeni na tiste, o katerih so že poročali v zvezi z uporabo zdravila GANFORT (večodmerna oblika) ali posameznih zdravilnih učinkovin, bimatoprosta ali timolola.
Do not use GANFORT single-dose after the expiry date which is stated on the single-dose container and the carton.
Zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na enoodmernem vsebniku in škatli poleg datuma izteka roka uporabnosti (EXP).
Respiratory disorders
Motnje dihanja
GANFORT may cause your eyelashes to darken and grow, and cause the skin around the eyelid to darken too.
Zdravilo GANFORT lahko povzroči temnenje in rast trepalnic, potemni pa vam lahko tudi koža okrog očesne veke.
This helps to stop GANFORT single-dose getting into the rest of the body.
Tako zdravilo GANFORT (enoodmerna oblika) ne pride drugam v telo.
Each pouch contains 10 single-dose containers.
Ena vrečica vsebuje 10 enoodmernih vsebnikov.
Ask your doctor for advice before taking any medicine during breast-feeding.
Če dojite, se posvetujte z zdravnikom, preden vzamete katero koli zdravilo.
GANFORT single-dose consists of two active substances: bimatoprost and timolol.
Zdravilo GANFORT je sestavljeno iz dveh zdravilnih učinkovin: bimatoprosta in timolola.
5 How to store GANFORT single-dose Contents of the pack and other information
Shranjevanje zdravila GANFORT (enoodmerna oblika) Vsebina pakiranja in dodatne informacije
Corneal diseases
Žilne bolezni
Affecting other parts of the body runny nose, dizziness, headache.
Učinki na druge dele telesa nahod, omotica, glavobol
In addition, signs and symptoms of beta-blockade (e.g. bradycardia, hypotension, respiratory distress and hypoglycaemia) have been observed in the neonate when beta-blockers have been administered until delivery.
Poleg tega so pri novorojencih opazili znake in simptome antagonistov adrenergičnih receptorjev beta (npr. bradikardija, hipotenzija, dihalna stiska in hipoglikemija), če so antagoniste adrenergičnih receptorjev beta uporabljali pred porodom.
If you stop using GANFORT
Če ste prenehali uporabljati zdravilo GANFORT
Eye disorders decreased corneal sensitivity1, diplopia1, ptosis1, choroidal detachment following filtration surgery (see section 4.4)1, keratitis1, blepharospasm2, retinal haemorrhage2, uveitis2,
ptoza1, odstop žilnice po filtracijskem kirurškem posegu (glejte poglavje 4.4)1, keratitis1, blefarospazem2, krvavitev mrežnice2, uveitis2
Ganfort contains a preservative called benzalkonium chloride.
Zdravilo GANFORT vsebuje konzervans benzalkonijev klorid.
Eye drops, solution, 3 x 3 ml
kapljice za oko, raztopina, 3 x 3 ml
- coronary heart disease (symptoms can include chest pain or tightness, breathlessness or choking),
- koronarno srčno bolezen (simptomi vključujejo bolečine ali stiskanje v prsih, zasoplost ali dušenje), srčno popuščanje, nizek krvni tlak;
Before treatment is initiated, patients should be informed of the possibility of eyelash growth, darkening of the eyelid or periocular skin and increased brown iris pigmentation since these have been observed during treatment with bimatoprost and GANFORT.
Pred zdravljenjem je treba bolnika obvestiti o možnih spremembah, ki so jih opazili med zdravljenjem z bimatoprostom in zdravilom GANFORT, to je o rasti trepalnic, temnenju kože veke ali periokularne kože in povečani rjavi pigmentaciji šarenice.
There is a potential for additive effects resulting in hypotension, and/or marked bradycardia when ophthalmic beta-blockers solution is administered concomitantly with oral calcium channel blockers, guanethidine, beta-adrenergic blocking agents, parasympathomimetics, anti-arrhythmics (including amiodarone) and digitalis glycosides.
Obstaja možnost aditivnih učinkov, ki lahko privedejo do hipotenzije in/ali znatne bradikardije, kadar se očesna raztopina antagonistov adrenergičnih receptorjev beta uporablja skupaj s peroralnimi zaviralci kalcijevih kanalov, gvanetidinom, antagonisti adrenergičnih receptorjev beta,
Table 1 presents the adverse reactions that were reported during clinical studies of both GANFORT single-dose and Ganfort multi-dose formulations (within each frequency grouping, adverse reactions are presented in order of decreasing seriousness) or in the post-marketing period.
Seznam neželenih učinkov v preglednici V preglednici 1 so predstavljeni neželeni učinki, o katerih so poročali med kliničnimi študijami zdravila GANFORT (pri enoodmerni oblika in večodmerni obliki) (v razvrstitvah pogostnosti so neželeni učinki navedeni po padajoči resnosti) ali v obdobju trženja.
As with any ocular treatment, if transient blurred vision occurs at instillation, the patient should wait until the vision clears before driving or using machines.
Tako kot pri drugih zdravilih za oči, lahko tudi zdravilo GANFORT povzroči prehodno zamegljen vid. Bolniki morajo pred vožnjo ali upravljanjem s stroji počakati, da simptomi minejo.
Therefore, GANFORT should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular oedema (e.g. intraocular surgery, retinal vein occlusions, ocular inflammatory disease and diabetic retinopathy).
Zato je potrebna previdnost pri uporabi zdravila GANFORT pri bolnikih z afakijo, bolnikih s psevdofakijo oziroma s poškodovano zadnjo lečno kapsulo in pri bolnikih z znanimi dejavniki tveganja za makularni edem (npr. intraokularna operacija, okluzija retinalne vene,
However, consideration should be given to the likelihood of compliance when considering either morning or evening dosing.
Vendar je pri izbiri jutranjega ali večernega odmerjanja treba upoštevati tudi, kaj bolniku bolj ustreza.
Fertility There are no data on the effects of GANFORT single-dose on human fertility.
Podatkov o učinkih zdravila GANFORT (enoodmerna oblika) na plodnost pri človeku ni.
The majority of adverse reactions reported in clinical studies using GANFORT were ocular, mild in severity and none were serious.
Večina neželenih učinkov, o katerih so poročali v kliničnih študijah zdravila GANFORT, je bila lokalnih in blagih.
As with any topical ocular treatment, if transient blurred vision occurs at instillation, the patient should wait until the vision clears before driving or using machines.
Tako kot pri drugih topičnih zdravilih za oči, lahko tudi zdravilo GANFORT povzroči prehodno zamegljen vid. Bolniki morajo pred vožnjo ali upravljanjem s stroji počakati, da simptomi minejo.
Benzalkonium chloride is known to discolour soft contact lenses.
Znano je, da benzalkonijev klorid spremeni barvo kontaktnih leč.
- If you have any further questions, please ask your doctor, pharmacist, or nurse.
- Če imate dodatna vprašanja, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
Timolol is partially metabolised by the liver with timolol and its metabolites excreted by the kidney.
Timolol se delno presnovi v jetrih, izloča pa se preko ledvic skupaj s svojimi presnovki.
• The active substances are bimatoprost 0.3 mg/ml and timolol 5 mg/ml corresponding to timolol maleate 6.8 mg/ml.
• Zdravilni učinkovini sta bimatoprost 0,3 mg/ml in timolol 5 mg/ml, v obliki 6,8 mg/ml timololijevega maleata.
Eye drops, solution, 3 ml
kapljice za oko, raztopina, 3 ml
Choroidal detachment
Jetrne okvare
Epidemiological studies have not revealed malformative effects but have shown a risk for intra uterine growth retardation when beta-blockers are administered by the oral route.
Epidemiološke študije niso pokazale škodljivih učinkov na razvoj ploda, vendar pa je bilo ob oralni uporabi antagonistovvadrenergičnih receptorjev beta ugotovljeno tveganje za upočasnitev intrauterine rasti.
These two components decrease elevated intraocular pressure (IOP) by complementary mechanisms of action and the combined effect results in additional IOP reduction compared to either compound administered alone.
Obe sestavini znižujeta povišan očesni tlak (IOT) s komplementarnim delovanjem.
GANFORT single-dose has a rapid onset of action.
Zdravilo GANFORT (enoodmerna oblika) začne delovati hitro.
Other medicines and GANFORT single-dose
Druga zdravila in zdravilo GANFORT (enoodmerna oblika)
5 How to store GANFORT Contents of the pack and other information
Shranjevanje zdravila GANFORT Vsebina pakiranja in dodatne informacije
If GANFORT is administered until delivery, the neonate should be carefully monitored during the first days of life.
uporabljalo pred porodom, je treba novorojenca prve dni po rojstvu skrbno opazovati.
Sodium chloride, sodium phosphate dibasic heptahydrate, citric acid monohydrate, hydrochloric acid or sodium hydroxide (to adjust pH) and purified water.
Natrijev klorid, natrijev dihidrogenfosfat heptahidrat, citronska kislina monohidrat, klorovodikova kislina ali natrijev hidroksid (za uravnavanje pH) in prečiščena voda.
GANFORT medicinal product
Shranjevanje zdravila GANFORT
What GANFORT looks like and contents of the pack
Izgled zdravila GANFORT in vsebina pakiranja
Alopecia2
neznana pogostnost alopecija2
Like other topically applied ophthalmic medicinal products, the active substances (timolol/ bimatoprost) in GANFORT single-dose may be absorbed systemically.
Kot pri drugih lokalnih očesnih zdravilih se tudi zdravilni učinkovini (timolol/bimatoprost) v zdravilu GANFORT (enoodmerna oblika) lahko absorbirata sistemsko.
If you are worried, talk to your doctor or pharmacist.
Če ste zaradi tega zaskrbljeni, se posvetujte z zdravnikom ali farmacevtom
Benzalkonium chloride, sodium chloride, sodium phosphate dibasic heptahydrate, citric acid monohydrate, hydrochloric acid or sodium hydroxide (to adjust pH) and purified water.
Benzalkonijev klorid, natrijev klorid, natrijev dihidrogenfosfat heptahidrat, citronska kislina monohidrat, klorovodikova kislina ali natrijev hidroksid (za uravnavanje pH) in prečiščena voda.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR SINGLE BOTTLE
PODATKI NA ZUNANJI OVOJNINI ŠKATLA ZA ENO PLASTENKO
These may affect more than 1 user in 10 Affecting the eye redness.
Pojavijo se lahko pri več kot 1 od 10 bolnikov
Keep the singledose containers in the pouch and place the pouch back in carton in order to protect against light and moisture.
Enoodmerne vsebnike hranite v vrečici in vrečico vrnite v škatlo, da zagotovite zaščito pred svetlobo in vlago.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON CONTAINING THREE BOTTLES
PODATKI NA ZUNANJI OVOJNINI ŠKATLA VSEBUJE TRI PLASTENKE
How to use GANFORT single-dose
Kako uporabljati zdravilo GANFORT (enoodmerna oblika)
Adverse reactions reported in phosphate containing eye drops
Drugi neželeni učinki kapljic za oko, ki vsebujejo fosfat
Cardiac disorder atrioventricular block1, cardiac arrest1, arrhythmia1, cardiac failure1, congestive heart failure1, chest pain1, palpitations1, oedema1
srčna odpoved1, kongestivna srčna odpoved1, bolečine v prsnem košu1, palpitacije1, edem1
If you stop using GANFORT single-dose
Če ste prenehali uporabljati zdravilo GANFORT (enoodmerna oblika)
Choroidal detachment has been reported with administration of aqueous suppressant therapy (e.g. timolol, acetazolamide) after filtration procedures.
Pri zdravljenju z zdravili, ki zavirajo nastanek očesne vodke (npr. timololom, acetazolamidom), so po filtracijskih posegih poročali o odstopanju žilnice.
Increased brown iris pigmentation has also been observed during treatment with GANFORT (multi-dose formulation).
Pri zdravljenju z zdravilom GANFORT (večodmerna oblika) je bila opažena tudi povečana rjava pigmentacija šarenice.
Affecting the eye abnormal sensation in the eye, iris inflammation, swollen conjunctiva (see-through layer of the eye), painful eyelids, tired eyes, in-growing eyelashes, darkening of iris colour, eyes appear sunken, eyelid has moved away from the surface of the eye, darkening of eyelashes.
Učinki na oko nenormalen občutek v očesu, vnetje šarenice, otekla očesna veznica (prozorna plast očesa), boleče veke, utrujene oči, vraščene trepalnice, temnenje barve šarenice, oči so videti udrte, odstop veke od površine očesa, temnenje trepalnic.
Common punctuate keratitis, corneal erosion2, burning sensation2, conjunctival irritation1, eye pruritus, stinging sensation in the eye2, foreign body sensation, dry eye, erythema of eyelid, eye pain, photophobia, eye discharge2, visual disturbance2, eyelid pruritus, visual acuity worsened2, blepharitis2, eyelid oedema, eye irritation, lacrimation increased, growth of eyelashes.
boleče oko, fotofobija, izcedek iz očesa2, motnje vida2, pruritus očesne veke, poslabšana ostrina vida2, blefaritis2, edem očesne veke, draženje oči, povečano solzenje, rast trepalnic občasni iritis2, edem očesne veznice2, bolečina v očesni veki2, neobičajen občutek v očesu1,
Like other topically applied ophthalmic medicinal products, the active substances (timolol/ bimatoprost) in GANFORT may be absorbed systemically.
Kot pri drugih lokalnih očesnih zdravilih se tudi zdravilni učinkovini (timolol/bimatoprost) v zdravilu GANFORT lahko absorbirata sistemsko.
Before treatment is initiated, patients should be informed of the possibility of eyelash growth, and periorbital skin hyperpigmentation since these have been observed during treatment with GANFORT single-dose.
Pred zdravljenjem je treba bolnika obvestiti o možnih spremembah, ki so jih opazili med zdravljenjem z zdravilom GANFORT (enoodmerna oblika), to je o rasti trepalnic in hiperpigmentaciji kože okoli očesne votline.
- disturbances of heart rate such as slow heart beat - breathing problems, asthma or chronic obstructive pulmonary disease - poor blood circulation disease (such as Raynaud's disease or Raynaud's syndrome) - overactivity of the thyroid gland as timolol may mask signs and symptoms of thyroid disease - diabetes as timolol may mask signs and symptoms of low blood sugar - severe allergic reactions - liver or kidney problems - eye surface problems - separation of one of the layers within the eyeball after surgery to reduce the pressure in the eye - known risk factors for macular oedema (swelling of the retina within the eye leading to worsening vision), for example, cataract surgery
- bolezen z motnjami v prekrvavitvi (kot je Raynaudova bolezen ali Raynaudov sindrom); - povečano delovanje žleze ščitnice, ker lahko timolol prikrije znake in simptome bolezni ščitnice; - sladkorno bolezen, ker lahko timolol prikrije znake in simptome nizkega krvnega sladkorja; - hude alergijske reakcije; - težave z jetri ali ledvicami;
Bimatoprost is a potent ocular hypotensive active substance.
Bimatoprost je močna zdravilna učinkovina za zmanjšanje očesnega tlaka.
From a microbiological point of view, the in-use storage times and conditions are the responsibility of the user and would normally not be longer than 28 days at 25°C.
Čas uporabe naj praviloma ne bi bil daljši od 28 dni pri temperaturi 25 °C.
The change may be more noticeable if you are only treating one eye. GANFORT may cause hair growth when in contact with the skin surface.
(enoodmerna oblika) lahko povzroči rast dlak, ko je v stiku s površino kože.
Do not use GANFORT single-dose if you are breast-feeding.
Zdravila GANFORT (enoodmerna oblika) ne uporabljajte, če dojite.
What GANFORT single-dose looks like and contents of the pack
Izgled zdravila GANFORT (enoodmerna oblika) in vsebina pakiranja
Keep single-dose containers in the pouch in order to protect from light and moisture.
Enoodmerne vsebnike hranite v verčici, za zagotovitev zaščite pred svetlobo in vlago.
Like other topically applied ophthalmic drugs, GANFORT (bimatoprost/timolol) is absorbed into the systemic circulation.
Kot pri drugih lokalnih očesnih zdravilih se tudi zdravilo GANFORT (bimatoprost/timolol) absorbira v sistemski krvni obtok.
Respiratory, thoracic and mediastinal disorders Asthma exacerbation2, COPD exacerbation2, cough1
Bolezni dihal, prsnega koša in mediastinalnega prostora poslabšanje astme2, poslabšanje KOPB2, kašelj1
Ophthalmic beta-blockers may induce dryness of eyes.
Očesni antagonisti adrenergičnih receptorjev beta lahko povzročijo suhost oči.
Vascular disorders
Odstopanje žilnice
GANFORT should not be used by breast-feeding women.
Doječe matere zdravila GANFORT ne smejo uporabljati.
Beta-blocking ophthalmological preparations may block systemic beta-agonist effects e.g. of adrenaline.
Kirurška anestezija Očesni antagonisti adrenergičnih receptorjev beta lahko zavirajo učinke sistemskih antagonistov adrenergičnih receptorjev beta, npr. adrenalina.
Each pack contains either 1 or 3 plastic bottles each with a screw-cap. Each bottle is about half full and contains 3 millilitres of solution.
Vsaka plastenka je napolnjena približno do polovice in vsebuje 3 ml raztopine.
Always use GANFORT single-dose exactly as your doctor or pharmacist has told you.
Pri uporabi zdravila GANFORT (enoodmerna oblika) natančno upoštevajte navodila zdravnika ali farmacevta.
In patients with a history of mild liver disease or abnormal alanine aminotransferase (ALT), aspartate aminotransferase (AST) and/or bilirubin at baseline, bimatoprost had no adverse reactions on liver function over 24 months.
Pri bolnikih z anamnezo blage bolezni jeter ali nenormalnimi izhodiščnimi vrednosti alanin aminotransferaze (ALT), aspartat-aminotransferaze (AST) in/ali celokupnega bilirubina, bimatoprost v
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON CONTAINING 30 SINGLE-DOSE CONTAINERS (PROVIDED IN 3 POUCHES, EACH CONTAINING 10 SINGLE-DOSE CONTAINERS)
ŠKATLA S 30 ENOODMERNIMI VSEBNIKI, SHRANJENIMI V 3 VREČICAH S PO 10 ENOODMERNIMI VSEBNIKI
Always use GANFORT exactly as your doctor or pharmacist has told you.
Pri uporabi zdravila GANFORT natančno upoštevajte navodila zdravnika ali farmacevta.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON CONTAINING 90 SINGLE-DOSE CONTAINERS (PROVIDED IN 9 POUCHES, EACH CONTAINING 10 SINGLE-DOSE CONTAINERS)
ŠKATLA Z 90 ENOODMERNIMI VSEBNIKI, SHRANJENIMI V 9 VREČICAH S PO 10 ENOODMERNIMI VSEBNIKI
• The other ingredients are benzalkonium chloride (a preservative), sodium chloride, sodium phosphate dibasic heptahydrate, citric acid monohydrate and purified water.
• Pomožne snovi: benzalkonijev klorid (konzervans), natrijev klorid, natrijev dihidrogenfosfat heptahidrat, citronska kislina monohidrat in prečiščena voda.
If you use GANFORT single-dose with another eye medicine, leave at least 5 minutes between putting in GANFORT single-dose and the other medicine.
Če poleg zdravila GANFORT uporabljate še kakšno drugo očesno zdravilo, je treba različna zdravila vkapati v razmiku najmanj 5 minut.
White opaque low-density polyethylene bottles with polystyrene screw cap. Each bottle has a fill volume of 3 ml.
Plastenka iz belega polietilena z majhno gostoto, z navojno zaporko iz polistirena.
GANFORT single-dose has not been studied in patients with hepatic or renal impairment.
Zdravilo GANFORT (enoodmerna oblika) ni bilo preizkušeno pri bolnikih z očesnimi vnetji,
The incidence of systemic ADRs after topical ophthalmic administration is lower than for systemic administration.
Incidenca sistemskih neželenih učinkov ob lokalni uporabi v očesu je nižja kot pri sistemski uporabi.
Uncommon iritis2, conjunctival oedema2, eyelid pain2, abnormal sensation in the eye1, asthenopia, trichiasis2, iris hyperpigmentation2, deepening of eyelid sulcus, eyelid retraction2, eyelash discolouration (darkening)1.
astenopija, trihiaza2, hiperpigmentacija šarenice2, poglobitev sulkusa veke, retrakcija veke2, razbarvanje trepalnic (potemnitev)1
GANFORT has not been studied in patients with hepatic or renal impairment.
Varnosti in učinkovitosti zdravila GANFORT pri bolnikih z okvaro jeter ali ledvic niso preučevali.
Pharmacotherapeutic group: Ophthalmological,- beta-blocking agents - ATC code: S01ED51
Oznaka ATC: S01ED51 Mehanizem delovanja
Skin and subcutaneous tissue disorders psoriasiform rash1 or exacerbation of psoriasis1, skin rash1 Musculoskeletal and connective tissue disorders myalgia1 Reproductive system and breast disorders sexual dysfunction1, decreased libido1
Bolezni kože in podkožja psoriaziformni izpuščaj1 ali poslabšanje psoriaze1, kožni izpuščaji1
Surgical anaesthesia β-blocking ophthalmological preparations may block systemic β-agonist effects e.g. of adrenaline.
Kirurška anestezija Očesni antagonisti adrenergičnih receptorjev beta lahko zavirajo učinke sistemskih antagonistov adrenergičnih receptorjev beta npr. adrenalina.
- if you are allergic to bimatoprost, timolol, beta-blockers or any of the other ingredients of GANFORT (listed in section 6) - if you have now or have had in past respiratory problems such as asthma, severe chronic obstructive bronchitis (severe lung disease which may cause wheeziness, difficulty in breathing and/ or long-standing cough) - if you have heart problems such as low heart rate, heart block, or heart failure
- če imate ali ste v preteklosti imeli bolezen dihal, kot je astma, hud kronični obstruktivni bronhitis (huda pljučna bolezen, ki lahko povzroči sopihanje, težave z dihanjem in/ali dolgotrajni kašelj);
Eye drops, solution, in single-dose container.
kapljice za oko, raztopina, v enoodmernem vsebniku brezbarvna do rahlo rumenkasta raztopina
• The other ingredients are sodium chloride, sodium phosphate dibasic heptahydrate, citric acid monohydrate and purified water.
• Pomožne snovi: natrijev klorid, natrijev dihidrogenfosfat heptahidrat, citronska kislina monohidrat in prečiščena voda.
Investigations liver function tests (LFT) abnormal2
Splošne težave in spremembe na mestu aplikacije astenija1,2 Preiskave nenormalni testi jetrne funkcije2
Respiratory, thoracic and mediastinal disorders
Bolezni dihal, prsnega koša in mediastinalnega prostora pogosti rinitis2
No new adverse reactions specific for GANFORT have been observed in clinical studies.
V kliničnih študijah niso opazili nobenih novih neželenih učinkov, ki bi bili značilni samo za zdravilo GANFORT.
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS BOTTLE
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH PLASTENKA
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR POUCH CONTAINING STRIP OF 5 SINGLE-DOSE CONTAINERS
PODATKI NA ZUNANJI OVOJNINI ŠKATLA ZA VREČICO S 5 ENOODMERNIMI VSEBNIKI
GANFORT 0.3 mg/ml + 5 mg/ml eye drops, solution, in single-dose container.
GANFORT 0,3 mg/ml + 5 mg/ml kapljice za oko, raztopina, v enoodmernem vsebniku.
GANFORT single-dose should not be used by breast-feeding women.
Doječe matere zdravila GANFORT (enoodmerna oblika) ne smejo uporabljati.
One ml of solution contains 0.3 mg bimatoprost and 5 mg timolol (as 6.8 mg of timolol maleate).
En ml raztopine vsebuje 0,3 mg bimatoprosta in 5 mg timolola (v obliki 6,8 mg timololijevega maleata).
GANFORT single-dose contains two different active substances (bimatoprost and timolol) that both reduce pressure in the eye. Bimatoprost belongs to a group of medicines called prostamides, a prostaglandin analogue.
Zdravilo GANFORT vsebuje dve različni zdravilni učinkovini (bimatoprost in timolol), ki obe znižujeta očesni tlak.
This helps to stop GANFORT getting into the rest of the body.
Tako zdravilo GANFORT ne pride drugam v telo.